The Indian patent, granted in a pharmaceutical market estimated at US $55 billion (Bain & Company) complements Innocan's global patent applications, strengthening the proprietary value of its ...

Roni Kamhi, CEO BI Sky Global and COO of Innocan Pharma commented: "We are very pleased with our outstanding results and especially our strong revenue growth. At BI Sky Global we are clearly ...

The company, with two endocrinology products approved by both the European Medicines Agency (EMA) and the U.S. Food & Drug Administration (FDA), is developing additional endocrinology and oncology ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Getting addicted, no pun intended, to an animated conspiracy thriller from Adult Swim ...

Get a deep dive into Sacre Bleu in this new trailer for the bullet-time action-platformer game. Learn more about combat, gameplay, speedrunning, game-modifiers, and more in this Sacre Bleu trailer.

COPENHAGEN, Denmark, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report third quarter 2024 financial results and provide a business update on ...

Further information can be found at: www.tmepharma.com. TME Pharma® and the TME Pharma logo are registered trademarks.

Further information can be found at: www.tmepharma.com. TME Pharma® and the TME Pharma logo are registered trademarks.

BENGALURU, May 15 (Reuters) - Indian pharmaceutical company Mankind Pharma (MNKI.NS), opens new tab posted a more than 65% rise in its fourth-quarter profit on Wednesday, helped by strong domestic ...

COPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2024 financial results and provide a business update on ...

Zoë Bleu (Gonzo Girl), daughter of actress Rosanna Arquette, is joining as Elisabeta/Mina, while rising Italian actress Matilda De Angelis, who plays the lead in AGBO and Amazon’s upcoming ...

He ran our group like a Ph.D. program. Before I left Isis Pharmaceuticals, I had almost 20 publications covering everything from gas-phase chemistry of nucleotides to structural analysis of native ...